Actuate Therapeutics, Inc. (ACTU)’s Elraglusib Elraglusib Trial Hits Key Goals in Pancreatic Cancer
Actuate Therapeutics, Inc.
Actuate Therapeutics Inc. (ACTU)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Voss Capital Travis Cocke | 286,140 | $1,748,315 | +101% | 0.12% |
| 2. | Tang Capital Management Kevin C. Tang | 5,243 | $32,035 | 0% | |
| 3. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 4. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.00 | 71,428 | $499,996.00 | 196,428 | 2025-06-27 | Filing | |
| $7.00 | 71,428 | $499,996.00 | 196,428 | 2025-06-27 | Filing | |
| $7.00 | 71,428 | $499,996.00 | 196,428 | 2025-06-27 | Filing | |
| $8.00 | 125,000 | $1,000,000.00 | 125,000 | 2024-08-14 | Filing | |
| $8.00 | 375,000 | $3,000,000.00 | 1,259,427 | 2024-08-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.00 | 2,324 | $18,592.00 | 131,248 | 2024-08-14 | Filing | |
| $8.00 | 17,361 | $138,888.00 | 980,433 | 2024-08-14 | Filing | |
| $8.00 | 5,314 | $42,512.00 | 300,143 | 2024-08-14 | Filing | |
| $8.00 | 2,324 | $18,592.00 | 131,248 | 2024-08-14 | Filing | |
| $8.00 | 17,361 | $138,888.00 | 980,433 | 2024-08-14 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 19,028 | $127,297 | 0.01% | |
| 2. | 6,488 | $43,405 | 0.08% | |
| 3. | 6,250 | $41,813 | 0% | |
| 4. | 201 | $1 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
